Episode notes
Mamas Mamas and Gi-byoung Nam discuss edoxaban monotherapy in patients with high-risk AF and stable CAD.
Podcast
Talking Points
TCTMD · Tech & Science · English
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b
More from Talking Points All episodes →
-
10 Dec 2025 · 6 min
The My Heart Your Heart Trial
Thomas Crawford meets with C. Michael Gibson to discuss the role of reconditioned pacemakers in low- and middle-income countries.
-
3 Dec 2025 · 14 min
The FAVOR III Europe Trial
Mamas Mamas, Birgitte Krogsgaard Andersen, and Niels Ramsing Holm discuss QFR versus FFR for guiding resvascularization in patients with coronary stenoses.
-
3 Dec 2025 · 6 min
The FLOW Trial
C. Michael Gibson talks to Katherine Tuttle about semaglutide's positive effects in patients with diabetes and chronic kidney disease.
-
19 Nov 2025 · 14 min
STORM-PE TRIAL
James Benenati, Robert Lookstein, and Rachel Rosovsky discuss the STORM-PE trial, the first-of-its-kind RCT for acute intermediate-high risk pulmonary embolism (PE).
-
12 Nov 2025 · 15 min
The EARLY TAVR and TAVR UNLOAD Trials
For patients with aortic stenosis, is earlier intervention beneficial? Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, and Bernard Prendergast discuss.
-
1 Oct 2025 · 8 min
The ECLIPSE Trial
Ajay Kirtane and C. Michael Gibson discuss how orbital atherectomy compares with balloon angioplasty for severely calcified coronary arteries before DES implantation.
-
17 Sep 2025 · 8 min
The CLEAR SYNERGY (OASIS 9) Trial
Does long-term colchicine benefit patients after acute MI? C. Michael Gibson and Sanjit Jolly discuss. 097245
-
3 Sep 2025 · 17 min
The NOTION-3 Trial
Mamas Mamas talks to Jacob Thomsen Lønborg about how PCI affects outcomes for patients with stable CAD undergoing TAVI.
-
15 Aug 2025 · 14 min
TMVR in the Heart Failure Paradigm
Transcatheter devices are new to the heart failure (HF) community and treatment armamentarium for severe MR. This discussion focuses on the impact of transcatheter devices on HF patients and current barriers faced by referring specialists.
-
13 Aug 2025 · 6 min
The ABYSS Trial
Johanne Silvain, Gilles Montalescot, and C. Michael Gibson discuss the effects of beta-blocker interruption in post-MI patients.
Take it with you
The Melo app keeps playing with the screen off, works in the car and on your watch, wakes you to your station, and browses the whole catalogue offline. Free, no ads, no account.
